We are live on ! Find out more
MTNB icon

Matinas BioPharma

54 hedge funds and large institutions have $20.3M invested in Matinas BioPharma in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.92% less ownership

Funds ownership: 12.53% → 11.62% (-0.92%)

16% less funds holding

Funds holding: 64 → 54 (-10)

76% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 17

89% less capital inflows, than outflows

Capital inflows: $221K | Capital outflows: $2.1M

Holders
54
Holders Change
-10
Holders Change %
-15.63%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
9
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MTNB Hedge Fund Activity: Q1 2022 in Review

54 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q1 2022, worth a combined $20.3M — down 26% from $27.4M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of MTNB and 4 opened new positions — a net loss of 13 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Private Advisor Group, adding an estimated $65.7K. The largest seller was Courage Capital Management, cutting an estimated $662K.

  • 54 institutional investors held Matinas BioPharma (MTNB) as of Q1 2022, down from 64 in Q4 2021.
  • Funds reported $20.3M of Matinas BioPharma stock for Q1 2022, down 26% quarter-over-quarter.
  • 4 funds opened new Matinas BioPharma positions in Q1 2022 and 17 closed out, a net change of -13 holders.
  • The largest Matinas BioPharma buyer in Q1 2022 was Private Advisor Group, an estimated $65.7K added.
  • The largest Matinas BioPharma seller in Q1 2022 was Courage Capital Management, an estimated $662K sold.

Based on aggregated 13F filings for Q1 2022.